Effect of actinomycin D, cycloheximide and puromycin on hepatic adenosine 3',5'-monophosphate in rats treated with glucagon.
D000818:Animals; D002250:Carbon Radioisotopes; D000242:Cyclic AMP / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D005934:Glucagon / Q000494:pharmacology*; D006207:Half-Life; D066298:In Vitro Techniques; D007930:Leucine / Q000037:antagonists & inhibitors / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009963:Orotic Acid / Q000037:antagonists & inhibitors / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology*; D012313:RNA / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D014316:Tritium; D003609:Dactinomycin; D011691:Puromycin; D009963:Orotic Acid; D012313:RNA; D005934:Glucagon; D003513:Cycloheximide; D000242:Cyclic AMP; D007930:Leucine